Mounjaro and low blood sugar: who needs a hypo plan?

Why Mounjaro with insulin or sulphonylureas raises the risk

Tirzepatide lowers glucose in a glucose-dependent way, but hypoglycaemia still happens. Insulin and sulphonylureas such as gliclazide raise the risk when you take them alongside tirzepatide. Eating less adds to the problem, especially if your existing doses were set for a different eating pattern.

Your prescriber may lower the dose of another diabetes medicine and arrange glucose monitoring. This is a planned clinical change. Do not stop insulin on your own. If you take Mounjaro only for weight management, without those medicines, your risk is different.

Hypo symptoms and checking your glucose

A hypo may cause sweating, shaking, hunger, a pounding heart, dizziness, blurred vision, irritability or confusion. Some of these overlap with dehydration, anxiety or other illness. When you can, check your glucose as your diabetes team advises before you treat every episode as low blood sugar.

The NHS usually describes a hypo as glucose below 4 mmol/L. Some people lose their warning symptoms, often after repeated episodes. A clear plan is more dependable than waiting for a familiar feeling.

Treating a hypo with your agreed plan

For someone awake who can swallow safely, NHS guidance is a fast-acting carbohydrate first. Recheck glucose after 10 to 15 minutes and repeat the treatment if the reading is still low. Once you recover, have a longer-lasting carbohydrate as appropriate. Agree the exact supplies and amounts with your diabetes team.

Preventing hypos at your prescription review

Talk through regular meals, exercise, alcohol, illness and driving. Carry hypo treatment with you if you are at risk. If you drive, follow the diabetes and licensing advice for your treatment and situation. Feeling better for a moment does not mean you are safe to drive again.

Tell your clinician about night-time episodes, repeated lows or any hypo where you needed someone else's help. A lower HbA1c is no win if recurrent hypoglycaemia comes with it. Your target should balance glucose control with safety.

Dose changes and a smaller appetite

Review the plan when you start tirzepatide, when the dose goes up and when your weight or food intake changes a lot. If a stomach illness stops you eating, follow your sick-day guidance and ask for advice early. Do not guess at dose changes.

Where you can, keep a record of readings, symptoms, meals and when you take each medicine. The pattern shows whether your insulin, sulphonylurea or another part of your treatment needs changing. If you do not have diabetes but keep getting symptoms of low blood sugar, get them assessed. Do not assume the injection explains them, and do not rely on your own reading of the symptoms.